- Clinical science
Mitral valve prolapse (MVP) is caused by a structural defect of the mitral valve that results in mitral leaflets bulging into the left atrium during systole. In the US, MVP is the most common heart valve abnormality and the most common cause of mitral regurgitation (MR). Although MVP is typically asymptomatic, symptoms (eg., palpitations, fatigue, dyspnea) may arise, especially if associated with MR. A mitral prolapse click is a classic auscultatory finding MVP and diagnosis is made with echocardiography. No specific treatment is needed unless severe, symptomatic MR is present, in which case mitral valve repair or replacement is required.
- Prevalance: 2–3% (one of the most common valvular abnormalities in the US)
- The most common cause of mitral regurgitation in developed countries
Epidemiological data refers to the US, unless otherwise specified.
- The most common underlying pathology in the case of mitral valve prolapse is myxomatous degeneration.
Mitral valve prolapse sets into motion a vicious cycle of events.
- If prolapse happens without the rupture of chordae tendineae → mitral valve leaflets billow into the left atrium → mild to moderate mitral regurgitation
- If the papillary muscles become severely ischemic and the chordae tendineae rupture → mitral valve leaflets flail about in the left atrium → severe mitral regurgitation
- Most patients are asymptomatic.
- Rarely: atypical chest pain and anxiety
- In case of complications: fatigue, dyspnea, syncope, and palpitations (see “Complications” below)
- Auscultatory findings
- Mitral valve prolapse click: high-frequency, midsystolic click that is best heard at the mitral region
- High-frequency, mid-to-late systolic murmur that is best heard at the mitral region and may radiate to the axilla.
- Patients with severe MR: S3 may be heard as a result of left ventricular overload (especially in the left decubitus position)
- ECG: mostly normal
- Transthoracic echocardiography (test of choice) to confirm diagnosis
- Transesophageal echocardiography (TEE) is used as an adjunct to TTE and intraoperatively to guide mitral valve repair procedures.
- Transient ischemic attacks ( ) and/or : Patients who experience TIA or stroke will require prophylactic doses of aspirin (also see “Therapy” in )
- : MVP patients with a past history of infective endocarditis require prophylaxis against infective endocarditis (see ).
We list the most important complications. The selection is not exhaustive.